Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases

Elizabeth N Pavlisko1, Victor L Roggli

  • 1Department of Pathology, Duke University Medical Center, Durham, NC.

Insights

Sarcomatoid peritoneal mesothelioma (SPe) is a rare cancer. This study characterized SPe, finding it predominantly affects males and is linked to asbestos exposure, with a poor prognosis.

Area of Science:

  • Oncology
  • Pathology

Background:

  • Peritoneal mesothelioma is rare, with the sarcomatoid variant (SPe) being exceptionally infrequent.
  • Existing literature primarily describes the morphology of SPe, with limited characterization of its clinicopathologic features.

Purpose of the Study:

  • To report the first large series detailing the clinicopathologic features of sarcomatoid peritoneal mesothelioma (SPe).

Main Methods:

  • Retrospective review of a malignant mesothelioma database, identifying cases with 100% sarcomatoid morphology via surgical biopsy or autopsy.
  • Inclusion of previously published cases to augment the total case count for analysis.

Main Results:

  • Identified 13 cases of SPe, representing 4% of peritoneal mesotheliomas and 0.5% of all mesotheliomas.
  • Median age at diagnosis was 66 years, with a male predominance (3.25:1). Median survival was 5 months.
  • Abdominal pain was the most common symptom; 69% of cases had evidence of asbestos exposure.

Conclusions:

  • Sarcomatoid peritoneal mesothelioma is a rare entity with distinct clinicopathologic features.
  • Asbestos exposure is a significant risk factor, and SPe is associated with a poor prognosis.